Heatstroke management during the COVID-19 epidemic: recommendations from the experts in Japan

    Acute Medicine & Surgery
    |August 25, 2020
    PubMed

    Insights

    Distinguishing COVID-19 from heatstroke is challenging due to similar symptoms like fever. This guidance provides essential recommendations for preventing and treating heatstroke during the pandemic, ensuring public safety.

    Area of Science:

    • Emergency Medicine
    • Public Health
    • Infectious Diseases

    Background:

    • Fever and hyperthermia are common symptoms of both COVID-19 and heatstroke, complicating differential diagnosis.
    • The COVID-19 pandemic created an urgent need for clear guidelines on heatstroke prevention and medical management.
    • Existing medical protocols required adaptation to address the unique challenges posed by the concurrent epidemics.

    Purpose of the Study:

    • To develop comprehensive guidance for heatstroke prevention and medical treatment during the COVID-19 pandemic.
    • To provide essential information for emergency medical personnel, including paramedics and nurses.
    • To address the clinical practice needs arising from the overlap in symptoms and public health concerns.

    Main Methods:

    • A joint working group was established by the Japanese Association for Acute Medicine, the Japanese Society for Emergency Medicine, the Japanese Association for Infectious Diseases, and the Japanese Respiratory Society.
    • Existing proposals on heatstroke prevention during the pandemic were reviewed and expanded upon.
    • Guidance was formulated based on expert consensus and the specific context of the COVID-19 epidemic.

    Main Results:

    • "Proposals on heatstroke prevention based on the COVID-19 epidemic" were issued on June 1, 2020.
    • The guidance addresses both preventative measures and clinical treatment strategies for heatstroke.
    • Recommendations are tailored for healthcare professionals involved in emergency care.

    Conclusions:

    • Clinical practice guidance is necessary for both heatstroke prevention and medical treatment in the context of the COVID-19 pandemic.
    • The established guidelines aim to improve patient outcomes by clarifying management strategies.
    • This supplementary recommendation serves as a crucial resource for healthcare providers during overlapping health crises.

    Related Concept Videos

    Methods of reducing fever01:22

    Methods of reducing fever

    The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
    Pharmacological Methods of Reducing Fever:
    1.1K
    Increased Body Temperature01:25

    Increased Body Temperature

    A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
    6.2K
    Decreased Body Temperature01:29

    Decreased Body Temperature

    A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
    871
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    95
    Myocarditis IV: Nursing Management01:22

    Myocarditis IV: Nursing Management

    Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
    134
    Homeostatic Imbalances in Body Temperature01:19

    Homeostatic Imbalances in Body Temperature

    Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...
    3.1K